Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10485154 | Value in Health | 2012 | 12 Pages |
Abstract
Despite similar comparators and logical differences due to transferability issues, the outcomes of the included studies varied widely. To increase comparability and transparency of pharmacoeconomic evaluations, standardization of modeling methods for different therapeutic groups/diseases and the availability of a detailed and complete description of the model used in the evaluation is advocated. Recommendations for standardization in modeling treatment strategies in early breast cancer are presented.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Gerardus W.J. MSc, Johan L. PhD, Anke M. PhD, Jan A.M. PhD, Jan H.M. MD, PhD,